Cargando…
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial
BACKGROUND: Although clozapine is the treatment of choice for treatment-refractory schizophrenia, 30–40% of patients have an insufficient response, and others are unable to tolerate it. Evidence for any augmentation strategies is scarce. We aimed to determine whether cognitive behavioural therapy (C...
Autores principales: | Morrison, Anthony P, Pyle, Melissa, Gumley, Andrew, Schwannauer, Matthias, Turkington, Douglas, MacLennan, Graeme, Norrie, John, Hudson, Jemma, Bowe, Samantha E, French, Paul, Byrne, Rory, Syrett, Suzy, Dudley, Robert, McLeod, Hamish J, Griffiths, Helen, Barnes, Thomas R E, Davies, Linda, Kingdon, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063993/ https://www.ncbi.nlm.nih.gov/pubmed/30001930 http://dx.doi.org/10.1016/S2215-0366(18)30184-6 |
Ejemplares similares
-
Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trial
por: Pyle, Melissa, et al.
Publicado: (2016) -
Methodological challenges designing pragmatic, multi-centre randomised controlled trials in critical care
por: MacLennan, Graeme, et al.
Publicado: (2013) -
Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)
por: Pyle, Melissa, et al.
Publicado: (2019) -
Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study
por: Morrison, Anthony P, et al.
Publicado: (2020) -
ScotCap – A large observational cohort study
por: MacLeod, Campbell, et al.
Publicado: (2022)